Ticker Symbol: THMO
ThermoGenesis Holdings Inc
$1.60 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000811212
Company Profile
ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
Sector: Manufacturing
Industry: Other Industrial Machinery Manufacturing
Standard Industrial Classification Code (SIC code): 3821
Address: 2711 Citrus Rd
Website: thermogenesis.com
CEO: Xiaochun Xu
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Other Industrial Machinery Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.15
Change:
-$0.05
(
-4.13%)
Days Range: $1.15 - $1.22
Beta: 1.49
52wk. High: $12.07
52wk. Low: $1.03
Ytd. Change -66.32%
50 Day Moving Average: $1.19
200 Day Moving Average: $1.46
Shares Outstanding: 2482298
Valuation
Market Cap: 287.9M
PE Ratio: -0.11
EPS (TTM): -10.45
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A